3 ms·
Reading the journal paper from AstraZeneca[1]. I don't think AZ can claim anything about preventing asymptomatic infections. You're right in that they're the on
by kenhwang 6y ago
Reading the journal paper from AstraZeneca[1]. I don't think AZ can claim anything about preventing asymptomatic infections. You're right in that they're the only ones with that data, but that data is practically identical between control (37/2760) and vaccinated (34/2751) groups.
Side note, the more I read about the AZ trials in detail, the more it becomes obvious how messy their trial was compared to the Pfizer/Moderna ones. They have so many more methodologies and outcomes and much smaller samples.
[1] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
- _Gyan_ 6y agoThey did find fewer asymptomatic infections in the half+full dose arm but the N is not large enough.